CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

Core Insights - CannaPharmaRX, Inc. is positioning itself as a leader in global cannabis cultivation and export, with a focus on expanding its operations in 2026 [1] International Export Activities - The company shipped an additional 250 kg of cannabis to Israel in Q4 2025, with plans for three more shipments in Q1 2026 [2] - Upcoming shipments will feature newly developed cannabis strains with higher THC concentrations, which are in high demand in the German medical cannabis market [3] New Strains - The new cannabis strains include Black Candyland, Goat Gas, Caligrape, Lemon Margy, Sour Chillz, and Mac & Cheese [4] Plans for 2026 - CannaPharmaRX plans to raise capital to enhance its European export capacity, including the construction of four additional cultivation rooms, a new drying room, and a post-harvest processing area compliant with EU-GMP standards [5] - These strategic investments are expected to support sustained profitability and long-term operational stability [6] Regulatory Update - The cease trade order issued by the British Columbia Securities Commission was officially revoked on December 12, 2025 [7]